TY  - BOOK
AU  - Wentian,He
AU  - Jimeno,Cecilia A.
AU  - Panelo,Carlo Irwin A.
TI  - Cost-effectiveness analysis of imidapril compared to metoprolol in the treatment of stage 1 essential hypertension among Filipino patients seen at the Philippine General Hospital
KW  - Metoprolol
KW  - Hypertension
KW  - therapy
KW  - Imidapril
N2  - OBJECTIVE: To evaluate the cost-effectiveness of imidapril versus metoprolol as monotherapy in Filipino patients with Stage 1 essential hypertension.


STUDY DESIGN: Cost-effectiveness analysis from the perspective of the health care payer.


METHOD: Medical records of 94 out-patients aged 40-70 years old, with Stage 1 essential hypertension and follow-up treatment of 3 months at the Philippine General Hospital were reviewed. Effectiveness of each drug was based on: 1) percentage of patients achieving target blood pressure (< 140 / 90 mmHg); and 2) mean reduction of systolic and diastolic blood pressure. Cost-effectiveness of each drug was evaluated using the criteria of cost-effectiveness ratio (CER) and the incremental cost-effectiveness ratio (ICER).


RESULTS: The mean cost of treatment with metoprolol was significantly lower than imidapril. However, treatment with imidapril resulted in a statistically significantly better blood pressure control compared to metoprolol; 77 percent of those given imidapril achieved the target BP vs 56 percent for metoprolol (p=0.03). CER and the ICER showed that 3-months treatment with metoprolol is more cost-effective than the use of imidapril.


CONCLUSION: Use of metoprolol over a 3-month period is more cost-effective than imidapril in the treatment of Filipino patients with Stage 1 essential hypertension
ER  -